Company profile

AMELIE

AMELIE (Anchored Muscle cELls for IncontinencE) is researching revolutionary cell therapy to treat faecal incontinence.

Industry
Research Services
Employees
20
Headquarters
London
Office locations
3

AMELIE company summary

AMELIE is a company in the Research Services industry, headquartered in London. On LinkedIn the company has around 20 employees. The company lists 3 office locations.

What technology does AMELIE use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About AMELIE

AMELIE (Anchored Muscle cELls for IncontinencE) is a 5-year collaborative research project funded by the European Union Framework Programme (Horizon 2020). It involves the collaboration of 13 organisations across nine countries to develop and carry out research. The project will be co-ordinated by UCL and led by Richard Day, Professor of Regenerative Medicine Technology at UCL. The consortium proposes a novel regenerative intervention using autologous skeletal muscle derived cells (ASMDC) to restore the function of the sphincter muscle. Scientists will attach ASMDC to implantable microcarriers to improve cell delivery and engraftment in patients with faecal incontinence. This will be tested in a randomised clinical trial. The strategy is expected to improve cell viability and increase the likelihood of muscle regeneration, contributing to improved continence. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874807.

Where is AMELIE located?

AMELIE lists 3 office locations.

London, GB, GBHQ
Lisbon, PT, PT
Madrid, ES, ES

Compare companies similar to AMELIE

More companies in Research Services.

CompanyIndustryEmployeesFoundedHeadquarters
AMELIE
amelie-project.eu
Research Services20-London
Google DeepMind
deepmind.google
Research Services10,0442010London, London, GB
PPD
ppd.com
Research Services20,326-Waltham, Massachusetts
Sony Research India
sonyresearchindia.com
Research Services792020Bengaluru, Karnataka
CERN
home.cern
Research Services8,1261954Meyrin, Genève
Research Services1,536-Bethesda, MD
Research Services4,9811901Gaithersburg, MD
Forrester
forrester.com
Research Services1,651-Cambridge, MA
CSIRO
csiro.au
Research Services6,785-Acton, ACT
Research Services5822007Saint-Josse-ten-Noode, Brussels
Research Services4,7391916Ottawa, Ontario

Frequently asked questions about AMELIE

What does AMELIE do?

AMELIE (Anchored Muscle cELls for IncontinencE) is a 5-year collaborative research project funded by the European Union Framework Programme (Horizon 2020). It involves the collaboration of 13 organisations across nine countries to develop and carry out research. The project will be co-ordinated by UCL and led by Richard Day, Professor of Regenerative Medicine Technology at UCL. The consortium proposes a novel regenerative intervention using autologous skeletal muscle derived cells (ASMDC) to restore the function of the sphincter muscle. Scientists will attach ASMDC to implantable microcarriers to improve cell delivery and engraftment in patients with faecal incontinence. This will be tested in a randomised clinical trial. The strategy is expected to improve cell viability and increase the likelihood of muscle regeneration, contributing to improved continence. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874807.

How many employees does AMELIE have?

AMELIE has around 20 employees on LinkedIn.

Where is AMELIE headquartered?

AMELIE is headquartered in London.

Where does AMELIE have offices?

AMELIE lists 3 office locations, including London, GB, GB; Lisbon, PT, PT; Madrid, ES, ES.

Build a lead list from companies like AMELIE

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.